News
NovaBridge Biosciences
NBP · NASDAQ
$1.43+$0.125 (+9.62%)TodayMarket closed ·
Prev close $1.30
Latest news
- Press releaseGlobe Newswire
Visara Secures Exclusive Option for Potential Acquisition of YOL104-2 for Ocular Surface Squamous Neoplasia
- News
Wuhan Hiteck Biological Pharma Enters Into Exclusive License Agreement With NovaBridge’s Visara For HT006.2.2, Investigational Next-Gen Modified rhNGF Eye Drop
- Press releasePRNewswire
Hiteck Licenses Investigational Next-Generation NGF Eye Drop HT006.2.2 to Visara for Neurotrophic Keratitis Outside Greater China
- Press releaseGlobe Newswire
Visara Expands Ophthalmology Pipeline with Exclusive License for Investigational Nerve Growth Factor Therapy for Neurotrophic Keratitis
- Press releaseGlobe Newswire
NovaBridge Biosciences Announces Expanded Givastomig Safety and Efficacy Data to be Presented at the European Society for Medical Oncology 2026
- News
12 Health Care Stocks Moving In Monday's After-Market Session
- News
NovaBridge Biosciences H1 2026 Earnings Call: Complete Transcript
- Press releaseGlobe Newswire
NovaBridge Appoints Martin Dewhurst to Board of Directors as an Independent Director
- Press releaseGlobe Newswire
NovaBridge Biosciences to Participate in September Investor Conferences
- Press releaseGlobe Newswire
NovaBridge Reports First Half 2026 Financial Results and Highlights Pipeline Momentum and Strategic Execution
- Press releaseGlobe Newswire
NovaBridge Biosciences to Hold Annual General Meeting on September 8, 2026
- Press releaseGlobe Newswire
NovaBridge to Present at the 2026 Jefferies Global Healthcare Conference
- Press releaseGlobe Newswire
NovaBridge to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference
- News
12 Health Care Stocks Moving In Tuesday's After-Market Session
- Press releaseGlobe Newswire
NovaBridge Reports Full Year 2025 Financial Results and Provides Business Update
- Press releaseGlobe Newswire
NovaBridge and Visara Announce Positive Results from VIS-101 Phase 2a Wet AMD Study
- Press releaseGlobe Newswire
NovaBridge to Host Business Update Call to Review Phase 2a Data for VIS-101 in Wet AMD on Monday, March 9, 2026
- Press releaseGlobe Newswire
NovaBridge to Present at the Leerink Partners 2026 Global Healthcare Conference
- News
12 Health Care Stocks Moving In Tuesday's After-Market Session
- Press releasePRNewswire
Functional Force: Precision Platforms Disrupt the 2026 Tumor Landscape
- News
12 Health Care Stocks Moving In Monday's After-Market Session
- News
12 Health Care Stocks Moving In Monday's After-Market Session
- News
12 Health Care Stocks Moving In Tuesday's After-Market Session
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.